Comment on Complications Following Antidotal Use of Intravenous Lipid Emulsion Therapy (Levine et al., J Med Toxicol 2013)

Samankaltaisia teoksia

• Other Complications Following Lipid Emulsion Therapy: Re: Levine M, Skolnik AB, Ruha AM, et al. (2013) Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol Dec 13. [Epub ahead of print]
  Tekijä: Schwarz, Evan S., et al.
  Julkaistu: (2014)
• Response to Letter to the Editor on Article: Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic Overdose Treated with Intravenous Fat Emulsion and High-dose Insulin in the Setting of Hypertrophic Cardiomyopathy. J Med Toxicol 2011; 7(2):151–3
  Tekijä: Stellpflug, Samuel J., et al.
  Julkaistu: (2011)
• Intravenous fat emulsion: A potential novel antidote
  Tekijä: Turner-Lawrence, Danielle E., et al.
  Julkaistu: (2008)
• Complications Following Antidotal Use of Intravenous Lipid Emulsion Therapy
  Tekijä: Levine, Michael, et al.
  Julkaistu: (2013)
• Physostigmine is the Antidote for Anticholinergic Syndrome
  Tekijä: Moore, Philip W., et al.
  Julkaistu: (2014)